OLFM4 and prostate carcinoma: In addition, AR-positive, androgen-sensitive VCaP prostate-cancer cells transiently overexpressing OLFM4 displayed reduced expression of SHH and GLI at the mRNA level but not the protein level (Supplementary Fig. S3).